FDA additions to Informed Consent – Will they help improve participant engagement?
By Paul Ivsin, Executive Vice President, Analytics, Insights, and Media If there is one thing we can agree on, it’s that informed consent forms (ICFs) for
By Paul Ivsin, Executive Vice President, Analytics, Insights, and Media If there is one thing we can agree on, it’s that informed consent forms (ICFs) for
Combined businesses unlock significant opportunity for clients with strategic, differentiated clinical trial recruitment, engagement and retention approaches, along with compelling creative solutions and best-in-class analytics.
Earlier this month, leaders at Continuum Clinical gained valuable insight into upcoming trends in clinical research, study sites, digital health, and the convergence of healthcare
Not connecting with a targeted audience, failing to retain patients throughout the enrollment process, and not having relationships with study coordinators at the site level
One of the key indicators of a clinical trial’s success is if the First Patient In is enrolled on time, or close to the goal.
Continuum Clinical’s MERIS Total Engagement Solution provides streamlined predictability to give confidence to Sponsors that their clinical trial milestones will be met. MERIS delivers an
By producing real-time, actionable performance data, the MERIS Total Engagement Solution is a game changing platform that sets a new standard for visibility into clinical
With 30 years of experience providing fact-based recruitment solutions, Continuum Clinical has established a track record of meeting and exceeding enrollment goals for clinical trials.
By Paul Ivsin, Senior Vice President, Analytics, Insights, and Media On Monday, May 22, the European Data Protection Board ordered Meta, Inc. to pay a
Provides streamlined predictability to give confidence to Sponsors that their clinical trial milestones will be met February 6, 2023, Northbrook, Ill. – Continuum Clinical, a
2001 Pennsylvania Avenue, NW
Washington, D.C. 20006